Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1232-7. doi: 10.1002/pds.1831.
To conduct a systematic review of current evidence regarding the use of health information technology (HIT) interventions to improve drug monitoring in ambulatory care.
We searched PubMed, CINAHL, the Cochrane Library, and other computerized databases from 1 January 1998 to 30 June 2008 using the key words "drug monitoring," "medical records systems, computerized," "ambulatory care," and "outpatients." We manually reviewed reference lists of articles identified through computer searches and asked experts in the field to review our search strategy and results for completeness.
Seven relevant studies were identified. Four of these studies assessed real-time interventions that used alerts to physicians at the time of medication ordering to ensure adequate monitoring, only one of which showed an improvement in monitoring. Of three studies using HIT outside the physician encounter, two suggested some improvement in monitoring rates. Methodological limitations were apparent in all studies identified.
Few studies have assessed the effectiveness of HIT interventions to improve drug monitoring, and among them, there is no clear consensus regarding the most consistently effective approaches to reducing drug monitoring errors. There is a clear need for well designed randomized trials to evaluate possible interventions to reduce drug monitoring errors. Such studies should incorporate health outcomes and detailed cost analyses to further characterize the feasibility of successful interventions.
系统评价目前关于使用健康信息技术(HIT)干预措施来改善门诊药物监测的证据。
我们检索了 1998 年 1 月 1 日至 2008 年 6 月 30 日的 PubMed、CINAHL、Cochrane 图书馆和其他计算机数据库,使用的关键词是“药物监测”、“医疗记录系统,计算机化”、“门诊医疗”和“门诊病人”。我们手动查阅了通过计算机搜索确定的文章的参考文献,并请该领域的专家审查我们的搜索策略和结果是否完整。
确定了 7 项相关研究。其中 4 项研究评估了实时干预措施,这些措施在医生开处方时向医生发出警报,以确保充分监测,其中只有一项显示出监测有所改善。在 3 项使用 HIT 进行医生就诊之外的研究中,有 2 项表明监测率有所提高。所有确定的研究都明显存在方法学局限性。
很少有研究评估 HIT 干预措施在改善药物监测方面的有效性,其中对于减少药物监测错误最有效的方法没有明确共识。显然需要精心设计的随机试验来评估可能的干预措施,以减少药物监测错误。这些研究应纳入健康结果和详细的成本分析,以进一步描述成功干预措施的可行性。